Adam Levy
Directeur Financier/CFO chez MINERALYS THERAPEUTICS, INC.
Fortune : 3 M $ au 31/05/2024
Postes actifs de Adam Levy
Sociétés | Poste | Début | Fin |
---|---|---|---|
MINERALYS THERAPEUTICS, INC. | Directeur Financier/CFO | 01/03/2022 | - |
Secrétaire Général | 01/03/2022 | - | |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Praxis Bioresearch LLC is a biopharmaceutical company based in the United States. The American company is focused on the discovery and development of therapeutics for chronic neuropsychiatric and neurodegenerative disorders. Praxis's lead development candidate is PRX-P4-003, a novel prodrug stimulant designed to offer the proven clinical activity of currently marketed stimulants while reducing the risk of abuse and addiction. PRX-P4-003 is being developed for the treatment of binge eating disorder and apathy in Alzheimer's disease. Sebastián Bernales and Sandeep Patil have been the CEOs since 2014. The private company was founded in 2014 by Sebastián Bernales, Rick E. Winningham, and Sandeep Patil. | Directeur/Membre du Conseil | 19/09/2023 | - |
Historique de carrière de Adam Levy
Anciens postes connus de Adam Levy
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Directeur Financier/CFO | - | 01/01/2022 |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Corporate Officer/Principal | 01/01/2019 | 01/01/2020 |
VIRIDIAN THERAPEUTICS, INC. | Investor Relations Contact | 13/02/2017 | - |
Corporate Officer/Principal | - | 26/07/2019 | |
VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2016 | 01/01/2019 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Corporate Officer/Principal | 01/09/2013 | 01/05/2016 |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Corporate Officer/Principal | 01/10/2009 | 01/04/2011 |
FRESH TRACKS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 | - |
░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Adam Levy
Cornell University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Espagne | 2 |
Opérationnelle
Corporate Officer/Principal | 7 |
Director of Finance/CFO | 2 |
Investor Relations Contact | 1 |
Sectorielle
Health Technology | 8 |
Finance | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
MINERALYS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Finance |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Finance |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Praxis Bioresearch LLC is a biopharmaceutical company based in the United States. The American company is focused on the discovery and development of therapeutics for chronic neuropsychiatric and neurodegenerative disorders. Praxis's lead development candidate is PRX-P4-003, a novel prodrug stimulant designed to offer the proven clinical activity of currently marketed stimulants while reducing the risk of abuse and addiction. PRX-P4-003 is being developed for the treatment of binge eating disorder and apathy in Alzheimer's disease. Sebastián Bernales and Sandeep Patil have been the CEOs since 2014. The private company was founded in 2014 by Sebastián Bernales, Rick E. Winningham, and Sandeep Patil. | Health Technology |